12 Health Care Stocks Moving In Friday’s After-Market Session
Gainers Longeveron (NASDAQ:LGVN) stock rose 48.6% to $3.27 during Friday’s after-market session. The company’s market cap stands at…
12 Health Care Stocks Moving In Wednesday’s Pre-Market Session
Gainers Lixte Biotechnology (NASDAQ:LIXT) shares moved upwards by 67.2% to $3.77 during Wednesday’s pre-market session. The market value…
Why MariaDB Shares Are Trading Higher By Around 100%; Here Are 20 Stocks Moving Premarket
Shares of MariaDB plc (NYSE: MRDB) rose sharply in today’s pre-market trading after Progress Software (NASDAQ: PRGS) announced that it is possibly considering an offer for the company.
12 Health Care Stocks Moving In Friday’s Pre-Market Session
Gainers China SXT Pharmaceuticals (NASDAQ:SXTC) stock increased by 25.2% to $2.73 during Friday’s pre-market session. The company’s market…
12 Health Care Stocks Moving In Tuesday’s Pre-Market Session
Gainers KalVista Pharma (NASDAQ:KALV) stock moved upwards by 31.5% to $21.1 during Tuesday’s pre-market session. The market value…
Why ReNew Energy Global Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Monday’s Mid-Day Session
Shares of ReNew Energy Global Plc (NASDAQ: RNW) gained during Monday’s session following strong quarterly sales.
ReNew Energy Global posted quarterly sales of $345.00 million, topping market estimates of $258.41 million.
Why Is Neuro-Oncology-Focused MediciNova Stock Trading Higher Today?
MediciNova Inc's (NASDAQ: MNOV) collaborators presented new data and results of a Phase 2 clinical trial of MN-166 (ibudilast) in glioblastoma (GBM) patients at the Annual Meeting of the
Why Applied UV Shares Are Trading Higher By Around 96%; Here Are 20 Stocks Moving Premarket
Shares of Applied UV, Inc. (NASDAQ: AUVI) shares jumped in pre-market trading after the company reported third-quarter results.
12 Health Care Stocks Moving In Monday’s Pre-Market Session
Gainers Altamira Therapeutics (NASDAQ:CYTO) stock rose 27.7% to $0.36 during Monday’s pre-market session. The company’s market cap stands…
MediciNova Announces New Data And Results Of A Phase 2 Clinical Trial Of MN-166 In Glioblastoma Presented At The 28th Annual Meeting Of The Society For Neuro-Oncology
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that MediciNova's collaborator,